Analysts expect XBiotech Inc. to report revenue of 6.77 M for Q1 21, against a range of 6.49 M to 7.04 M.
| Metric | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | - | - | - | - | - | - | - | - | ||||||||
| High Estimate | 7.04 M | 7.96 M | 7.83 M | 6.91 M | 7.28 M | 7.78 M | 7.54 M | 7.15 M | ||||||||
| Low Estimate | 6.49 M | 6.73 M | 6.92 M | 6.39 M | 6.32 M | 6.54 M | 6.84 M | 6.33 M | ||||||||
| Consensus Estimate | 6.77 M | 7.35 M | 7.38 M | 6.65 M | 6.80 M | 7.16 M | 7.19 M | 6.74 M |
Analysts expect XBiotech Inc. to report earnings per share of 0.04 for Q1 21, against a range of 0.04 to 0.04.
| Metric | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | - | - | - | - | - | - | - | - | ||||||||||||
| High Estimate | 0.04 | 0.03 | 0.03 | 0.02 | -0.27 | -0.27 | -0.28 | -0.25 | ||||||||||||
| Low Estimate | 0.04 | 0.03 | 0.03 | 0.02 | -0.31 | -0.31 | -0.30 | -0.29 | ||||||||||||
| Consensus Estimate | 0.04 | 0.03 | 0.03 | 0.02 | -0.29 | -0.29 | -0.29 | -0.27 |